Brandon Bergschneider
Medical · Tallahassee, FLNPI 1578981742
Payments from drug & device makers
Across 379 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$729
- Johnson & Johnson$716
- Sun Pharmaceutical Industries Inc.$669
- Sanofi$535
- Pfizer$532
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,72795%
- Education$3405%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,203 |
| Novartis | 46 | $729 |
| Johnson & Johnson | 37 | $716 |
| Sun Pharmaceutical Industries Inc. | 26 | $669 |
| Sanofi | 26 | $535 |
| Pfizer | 32 | $532 |
| Lilly USA, LLC | 22 | $433 |
| LEO Pharma Inc. | 21 | $397 |
| UCB, Inc. | 25 | $338 |
| Amgen | 11 | $227 |
| Mayne Pharma Commercial LLC | 10 | $222 |
| Incyte Corporation | 11 | $201 |
| Regeneron Healthcare Solutions, Inc. | 11 | $175 |
| Organogenesis Inc. | 7 | $150 |
| Boehringer Ingelheim | 5 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $90 |
| Kerecis Limited | 5 | $89 |
| Almirall LLC | 4 | $71 |
| Organon | 2 | $42 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Novo Nordisk | 1 | $22 |
| Biofrontera Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Misonix Inc | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,067 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $266,732 |
| Clobetasol Propionate | 98 | $3,367 |
| Doxycycline Hyclate | 75 | $1,638 |
| Triamcinolone Acetonide | 83 | $977 |
| Metronidazole | 17 | $937 |
| Clindamycin Phosphate | 31 | $836 |
| ValacyclovirValacyclovir Hcl | 16 | $835 |
| Ketoconazole | 39 | $700 |
| Fluocinonide | 11 | $510 |
| CiclopiroxCiclopirox Olamine | 11 | $444 |
| Mupirocin | 39 | $320 |
| Ammonium Lactate | 13 | $260 |
| Prednisone | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other medical in Tallahassee
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.